BrightAccountsProduction v1.0.0 v1.0.0 2024-06-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The principal activity of the company continues to be the sale of analytical tools used in the Biotech sector. 8 January 2026 0 0 08546932 2025-05-31 08546932 2024-05-31 08546932 2023-05-31 08546932 2024-06-01 2025-05-31 08546932 2023-06-01 2024-05-31 08546932 uk-bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 08546932 uk-curr:PoundSterling 2024-06-01 2025-05-31 08546932 uk-bus:AbridgedAccounts 2024-06-01 2025-05-31 08546932 uk-core:ShareCapital 2025-05-31 08546932 uk-core:ShareCapital 2024-05-31 08546932 uk-core:RetainedEarningsAccumulatedLosses 2025-05-31 08546932 uk-core:RetainedEarningsAccumulatedLosses 2024-05-31 08546932 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2025-05-31 08546932 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2024-05-31 08546932 uk-core:RetainedEarningsAccumulatedLosses 2024-06-01 2025-05-31 08546932 uk-bus:FRS102 2024-06-01 2025-05-31 08546932 uk-core:MotorVehicles 2024-06-01 2025-05-31 08546932 2024-06-01 2025-05-31 08546932 uk-bus:Director1 2024-06-01 2025-05-31 08546932 uk-bus:AuditExempt-NoAccountantsReport 2024-06-01 2025-05-31 xbrli:pure iso4217:GBP xbrli:shares

Antech Scientific Limited

Abridged Unaudited Financial Statements

for the financial year ended 31 May 2025

Antech Scientific Limited

DIRECTOR'S REPORT

for the financial year ended 31 May 2025

The director presents their report and the unaudited financial statements for the financial year ended 31 May 2025.

Director

The director who served during the financial year is as follows:

Dermot Harrington

There were no changes in shareholdings between 31 May 2025 and the date of signing the financial statements.

Political Contributions

The company did not make any disclosable political donations in the current financial year.

Statement of Director's Responsibilities

The director is responsible for preparing the Director's Report and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" Section 1A (Small Entities). Under company law the director must not approve the financial statements unless they is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to:

- | select suitable accounting policies and apply them consistently;
- | make judgements and accounting estimates that are reasonable and prudent;
- | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Special provisions relating to small companies

The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.

On behalf of the board

Dermot Harrington

Director

8 January 2026

Antech Scientific Limited

ABRIDGED INCOME STATEMENT

for the financial year ended 31 May 2025

|  | 2025 |  | 2024
| Notes | £ |  | £

Gross profit |  | 88,252 |  | 83,012
Administrative expenses |  | (87,465) |  | (96,191)
|  | ───────── |  | ─────────
Operating profit/(loss) |  | 787 |  | (13,179)
Interest receivable and similar income |  | 147 |  | 114
|  | ───────── |  | ─────────
Profit/(loss) before taxation |  | 934 |  | (13,065)
Tax on profit/(loss) |  | - |  | -
|  | ───────── |  | ─────────
Profit/(loss) for the financial year |  | 934 |  | (13,065)
|  | ───────── |  | ─────────
Total comprehensive income |  | 934 |  | (13,065)
|  | ═════════ |  | ═════════

Antech Scientific Limited

Company Registration Number: 08546932

ABRIDGED STATEMENT OF FINANCIAL POSITION

as at 31 May 2025

|  |  | 2025 |  | 2024
|  | Notes | £ |  | £
Non-Current Assets

Property, plant and equipment |  | 4 | 9,375 |  | 15,625
|  |  | ───────── |  | ─────────
Current Assets

Debtors |  |  | 14,821 |  | 30,005
Cash and cash equivalents |  |  | 165,386 |  | 144,315
|  |  | ───────── |  | ─────────
|  |  | 180,207 |  | 174,320
|  |  | ───────── |  | ─────────
Creditors: amounts falling due within one year |  |  | (33,058) |  | (34,355)
|  |  | ───────── |  | ─────────
Net Current Assets |  |  | 147,149 |  | 139,965
|  |  | ───────── |  | ─────────
Total Assets less Current Liabilities |  |  | 156,524 |  | 155,590
|  |  | ═════════ |  | ═════════
Capital and Reserves

Called up share capital |  |  | 100 |  | 100
Retained earnings |  |  | 156,424 |  | 155,490
|  |  | ───────── |  | ─────────
Equity attributable to owners of the company |  |  | 156,524 |  | 155,590
|  |  | ═════════ |  | ═════════
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).

All of the members have consented to the preparation of abridged accounts in accordance with section 444(2A) of the Companies Act 2006.

For the financial year ended 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Approved by the Director and authorised for issue on 8 January 2026

Dermot Harrington |  |  |  |  |
Director |  |  |  |  |

Antech Scientific Limited

STATEMENT OF CHANGES IN EQUITY

as at 31 May 2025

| Called up | Retained | Total
| share | earnings |
| capital |  |
| £ | £ | £
At 1 June 2023 | 100 | 168,555 | 168,655
| ───────── | ───────── | ─────────
Loss for the financial year | - | (13,065) | (13,065)
| ───────── | ───────── | ─────────
At 31 May 2024 | 100 | 155,490 | 155,590
| ───────── | ───────── | ─────────
Profit for the financial year | - | 934 | 934
| ───────── | ───────── | ─────────
At 31 May 2025 | 100 | 156,424 | 156,524
| ═════════ | ═════════ | ═════════

Antech Scientific Limited

NOTES TO THE ABRIDGED FINANCIAL STATEMENTS

for the financial year ended 31 May 2025

1. | General Information
| Antech Scientific Limited is a company limited by shares incorporated in England. The registered office of the company is Wisteria Grange Barn, Pikes End, Pinner, London, HA5 2EX, United Kingdom which is also the principal place of business of the company. The principal activity of the company continues to be the sale of analytical tools used in the Biotech sector. The financial statements have been presented in Pound (£) which is also the functional currency of the company.

2. | Summary of Significant Accounting Policies
| The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
| Statement of compliance
| The financial statements of the company for the year ended 31 May 2025 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
| Basis of preparation
| The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
| Turnover
| Turnover is recognised to the extent that the company obtains the right to consideration in exchange for its performance. Turnover comprises the fair value of consideration received and receivable exclusive of value added tax and after discounts and rebates. Where the consideration receivable in cash or cash equivalents is deferred, and the arrangement constitutes a financing transaction, the fair value of the consideration is measured as the present value of all future receipts using the imputed rate of interest. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer, usually on dispatch of the goods, the amount of turnover can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
| Property, plant and equipment and depreciation
| Property, plant and equipment are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of property, plant and equipment, less their estimated residual value, over their expected useful lives as follows:
|  | Motor vehicles | - | 25% Straight line
| Assets not carried at fair value are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognised for the amount by which the asset’s carrying amount exceeds its recoverable amount. The recoverable amount is the higher of an asset’s fair value less costs to sell and value in use. Value in use is defined as the present value of the future pre-tax and interest cash flows obtainable as a result of the asset’s continued use. The pre-tax and interest cash flows are discounted using a pre-tax discount rate that represents the current market risk free rate and the risks inherent in the asset. For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows (cash-generating units). If the recoverable amount of the asset (or asset’s cash generating unit) is estimated to be lower than the carrying amount, the carrying amount is reduced to its recoverable amount. An impairment loss is recognised in the profit and loss account, unless the asset has been revalued when the amount is recognised in other comprehensive income to the extent of any previously recognised revaluation. Thereafter any excess is recognised in profit or loss. If an impairment loss is subsequently reversed, the carrying amount of the asset (or asset’s cash generating unit) is increased to the revised estimate of its recoverable amount, but only to the extent that the revised carrying amount does not exceed the carrying amount that would have been determined (net of depreciation) had no impairment loss been recognised in prior periods. A reversal of an impairment loss is recognised in the profit and loss account.
| Fully depreciated property, plant & equipment are retained in the cost of property, plant & equipment and related accumulated depreciation until they are removed from service. In the case of disposals, assets and related depreciation are removed from the financial statements and the net amount, less proceeds from disposal, is charged or credited to the profit and loss account.
| Trade and other debtors
| Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
| Cash and cash equivalents
| Cash and cash equivalents comprise cash at bank and in hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less and bank overdrafts. In the Abridged Statement of Financial Position bank overdrafts are shown within Creditors.
| Trade and other creditors
| Creditors and accruals are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.
| Taxation and deferred taxation
| Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Statement of Financial Position date. Deferred tax arises from timing differences that are differences between taxable profits and total comprehensive income as stated in the financial statements. These timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is provided in full on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements. Deferred tax is determined using tax rates (and laws) that have been enacted or substantively enacted by the balance sheet date and are expected to apply when the related deferred income tax asset is realised or the deferred tax liability is settled. Deferred tax is determined using tax rates (and laws) that have been enacted or substantively enacted by the balance sheet date and are expected to apply when the related deferred income tax asset is realised or the deferred tax liability is settled. Deferred tax is recognised in the profit and loss account or other comprehensive income depending on where the revaluation was initially posted. Deferred tax assets are recognised to the extent that it is probable that future taxable profits will be available against which the temporary differences can be utilised. Current or deferred taxation assets and liabilities are not discounted.
| Foreign currencies
| Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Statement of Financial Position date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Income Statement.
| Ordinary share capital
| The ordinary share capital of the company is presented as equity.

3. | Employees
| The average monthly number of employees, including director, during the financial year was 0, (2024 - 0).

4. | Property, plant and equipment
|  | Motor | Total
|  | vehicles |
|  | £ | £
| Cost
| At 1 June 2024 | 75,204 | 75,204
|  | ───────── | ─────────
| At 31 May 2025 | 75,204 | 75,204
|  | ───────── | ─────────
| Depreciation
| At 1 June 2024 | 59,579 | 59,579
| Charge for the financial year | 6,250 | 6,250
|  | ───────── | ─────────
| At 31 May 2025 | 65,829 | 65,829
|  | ───────── | ─────────
| Net book value
| At 31 May 2025 | 9,375 | 9,375
|  | ═════════ | ═════════
| At 31 May 2024 | 15,625 | 15,625
|  | ═════════ | ═════════

5. | Capital commitments
| The company had no material capital commitments at the financial year-ended 31 May 2025.